Development and Validation of a Bioanalytical HPLC Method for Quantification of Valsartan in Human Plasma and its Application in Pharmacokinetics Studies

References

• Spínola, A.C.F., Almeida, S., Filipe, A., Neves, R., Trabelsi, F. and Farré, A. (2009). Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions Clin. Ther. 31: 1992–2001.
   PubMed Web of Science ®Google Scholar
• Cardiology, A.C.O. (2004). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-Executive summary J. Am. Coll. Cardiol. 44: 671–719. doi: 10.1016/j.jacc.2004.07.002
   PubMedGoogle Scholar
• Daneshtalab, N., Lewanczuk, R.Z. and Jamali, F. (2002). High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method. J. Chromatogr. B. 766: 345–349. doi: 10.1016/S0378-4347(01)00507-2
   PubMed Web of Science ®Google Scholar
• Waldmeier, F., Flesch, G., Mu Ller, P., Winkler, T., Kriemler, H.-P., Buhlmayer, P. and De Gasparo, M. (1997). Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose. Xenobiotica. 27: 59–71. doi: 10.1080/004982597240767
   PubMed Web of Science ®Google Scholar
• Hillaert, S. and Van den Bossche, W. (2003). Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis. J. Pharm. Biomed. Anal. 31: 329–339. doi: 10.1016/S0731-7085(02)00643-X
   PubMed Web of Science ®Google Scholar
• Doshi, A.S., Bhagwan, S.S., Mehta, T.N., Gupta, V.K. and Subaaiah, G. (2008). Determination of nebivolol and valsartan in a fixed-dose combination by liquid chromatography J. AOAC Int. 91: 292–298.
   PubMed Web of Science ®Google Scholar
• Mohamed, N.G. (2011). Simultaneous determination of amlodipine and valsartan. Anal. Chem. Insights. 6, ACI. S7282. doi: 10.4137/ACI.S7282
   Google Scholar
• Del Rosario Brunetto, M., Contreras, Y., Clavijo, S., Torres, D., Delgado, Y., Ovalles, F., Ayala, C., Gallignani, M., Estela, J.M. and Martin, V.C. (2009). Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection. J. Pharm. Biomed. Anal. 50: 194–199. doi: 10.1016/j.jpba.2009.04.015
   PubMed Web of Science ®Google Scholar
• Rao, R.N., Raju, S.S. and Vali, R.M. (2013). Ionic-liquid based dispersive liquid-liquid microextraction followed by high performance liquid chromatographic determination of anti-hypertensives in rat serum. J. Chromatog. B. 931: 174–180. doi: 10.1016/j.jchromb.2013.05.027
   PubMed Web of Science ®Google Scholar
• Tekkeli, K. and Evrim, S. (2013). Development of an HPLC-UV method for the analysis of drugs used for combined hypertension therapy in pharmaceutical preparations and human plasma. J. Anal. Methods Chem. 2013.
   Web of Science ®Google Scholar
• Gadepalli, S.G., Deme, P., Kuncha, M. and Sistla, R. (2014). Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LC-ESI-MS/MS and its application to pharma-cokinetics in rats. J. Pharm. Anal. 4: 399–406. doi: 10.1016/j.jpha.2013.12.003
   PubMedGoogle Scholar
• Shah, J.V., Parekh, J.M., Shah, P.A., Shah, P.V., Sanyal, M. and Shrivastav, P.S. (2017). Application of an LC–MS/MS method for the analysis of amlodipine, valsartan and hydrochloro-thiazide in polypill for a bioequivalence study. J. Pharm. Anal. 7: 309–316. doi: 10.1016/j.jpha.2017.06.001
   PubMed Web of Science ®Google Scholar
• Babarahimi, V., Talebpour, Z., Haghighi, F., Adib, N. and Vahidi, H. (2018). Validated determination of losartan and valsartan in human plasma by stir bar sorptive extraction based on acrylate monolithic polymer, liquid chromatographic analysis and experimental design methodology J. Pharm. Biomed. Anal. 153: 204–213. doi: 10.1016/j.jpba.2018.02.030
   PubMed Web of Science ®Google Scholar
• Brunner, L.A., Powell, M.L., Degen, P. and Flesch, G. (1994). Semiautomated Analytical Method for the Determination of Potential Antihypertensive Agents (cgp 48933 and or cgp 48369) in Human Plasma using High-Performance Liquid-Chromatography. Lab. Robotics Automat. 6: 171–179.
   Google Scholar
• Sioufi, A., Marfil, F. and Godbillon, J. (1994). Automated determination of an angiotensin II receptor antagonist, CGP 48 933, in plasma by high-performance liquid chromatography. J. Liq. Chromatogr. Relat. Technol. 17: 2179–2186. doi: 10.1080/10826079408013539
   Web of Science ®Google Scholar
• Gonzalez, L., Lopez, J., Alonso, R. and Jimenez, R. (2002). Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. A. 949: 49–60. doi: 10.1016/S0021-9673(01)01496-0
   PubMed Web of Science ®Google Scholar
• Sechaud, R., Graf, P., Bigler, H., Gruendl, E., Letzkus, M. and Merz, M. (2002). Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design. Int. J. Clin. Pharmacol. Ther. 40: 35–40. doi: 10.5414/CPP40035
   PubMed Web of Science ®Google Scholar
• Mak, W., Tan, S., Wong, J., Chin, S. and Lim, A. (2015). Bioequivalence Study of Two Valsartan 160 mg Formulations: An Open-Label, Randomised-Sequence, Single-Dose, Two-Way Crossover Study in Healthy Volunteers under Fasting Conditions. J Bioequiv. Availab. 7: 179–183.
   Google Scholar
• Pérez, M., Cárdenas, W., Ramírez, G., Pérez, M. and Restrepo, P. (2006). Comparative, crossover, double blind, randomized study for bioequivalence assessment between two formulations of valsartan capsules vs. tablets. Colomb. Méd. 37: 107-113.
   Google Scholar
• Piao, Z.-Z., Lee, E.-S., Tran, H. T. T. and Lee, B.-J. (2008) Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection. Arch. Pharm. Res. 31: 1055-1059. doi: 10.1007/s12272-001-1268-4
   PubMed Web of Science ®Google Scholar
• Iqbal, M., Khuroo, A., Batolar, L. S., Tandon, M., Monif, T. and Sharma, P. (2010). Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a singledose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers. Clin. Ther. 32: 588–596. doi: 10.1016/j.clinthera.2010.03.004
   PubMed Web of Science ®Google Scholar
• Koseki, N., Kawashita, H., Hara, H., Niina, M., Tanaka, M., Kawai, R., Nagae, Y. and Masuda, N. (2007). Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 43: 1769–1774. doi: 10.1016/j.jpba.2006.12.030
   PubMed Web of Science ®Google Scholar
• Kim, J.-E., Ki, M.-H., Yoon, I.-S., Cho, H.-J., Kim, R.-S., Kim, G. T. and Kim, D.-D. (2014). Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: a randomized, single-dose, 2-period crossover study in healthy Korean male volunteers. Clin. Ther. 36: 273–279. doi: 10.1016/j.clinthera.2014.01.004
   PubMed Web of Science ®Google Scholar
• FDA (2013). bioanalytical method validation. US Departmentof Health and Human Services, Food and Drug Administration, Center for DrugEvaluation and Research (CDER), Center for Veterinary Medicine (CVM) in (FDA, ed).
   Google Scholar
• Association, W.M. (2013). World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, Jama. 310: 2191-2194. doi: 10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Nadeem, S., Asif, H., Lakshita, C., M Shamsher, A., Moloy, M. and Parminder, S.B. (2011). Pharmacological and Pharmaceutical Profile of Valsartan: A Review. J. Appl. Pharm. Sci. 01(04): 12–19.
   Google Scholar